Acadia Pharmaceuticals | 销售成本



Cost Of Sales 更改 日
Acadia Pharmaceuticals USD 21.8M 2.95M 2024-12
ALKERMES USD 62.12M 984K 2024-12
Alnylam Pharmaceuticals USD 102.82M 16.91M 2024-12
Biogen USD 583.5M 55.2M 2024-12
BioMarin Pharmaceutical USD 136.14M 52.32M 2024-12
Bristol-Myers Squibb USD 3.21B 356M 2024-12
Corcept Therapeutics USD 2.96M 89K 2024-12
Cytokinetics 463K 79.14M 2024-09
Eisai JPY 45.94B 3.42B 2024-12
Eli Lilly USD 2.4B 233M 2024-12
Incyte USD 82.38M 2.49M 2024-12
J&J USD 7.3B 189M 2025-03
Moderna USD 546M 246M 2024-12
Neurocrine Biosciences USD 9.3M 1.3M 2024-12
Pfizer USD 5.65B 781M 2024-12
Prothena 970K 4.78M 2024-09
PTC Therapeutics USD 16.28M 5.44M 2024-12
Sarepta Therapeutics USD 132.3M 40.61M 2024-12
Ultragenyx Pharmaceutical USD 16.89M 4.13M 2024-12
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12



Acadia Pharmaceuticals 销售成本 - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2025.